We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.13 | -1.75% | 7.30 | 7.29 | 7.37 | 7.425 | 7.26 | 7.38 | 6,172,284 | 21:03:38 |
From Apr 2021 to Apr 2024
By Cristina Roca
Bayer AG said Tuesday that it will spend more than 400 million euros ($464.8 million) to expand its production capabilities as part of its goal of increasing access to contraception for women in less wealthy countries.
The German pharmaceutical-and-chemical conglomerate will build a new production facility in Alajuela, Costa Rica. It will also build a new facility and expand its production capability in Turku, Finland, the company said.
Both sites will produce hormonal implants and hormonal intrauterine systems, and will support the company's goal of giving 100 million women in low- and middle-income countries access to family planning by 2030, Bayer said.
Write to at cristina.roca@wsj.com
(END) Dow Jones Newswires
October 05, 2021 03:05 ET (07:05 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
